Cencora, Inc. (COR) EPS Basic: 13.04
Is Cencora, Inc.’s EPS basic high or low?
Cencora, Inc.'s EPS basic of 13.04 is 236% above its 5-year average of 3.88, near the high end of its 5-year range (-16.60–13.04).
66.97% above its 12-month average of 7.81.
COR EPS Basic Chart
COR Average EPS Basic Chart
COR Current vs Average EPS Basic Chart
COR EPS Basic Metrics
EPS BASIC
13.04
EPS BASIC AVG TTM
7.81
EPS BASIC AVG 3Y
8.10
EPS BASIC AVG 5Y
3.88
EPS BASIC AVG 10Y
3.88
EPS BASIC AVG 15Y
3.34
EPS BASIC AVG 20Y
2.82
CURRENT VS TTM AVG
+66.97%
CURRENT VS 3Y AVG
+61.04%
CURRENT VS 5Y AVG
+236.23%
CURRENT VS 10Y AVG
+235.69%
CURRENT VS 15Y AVG
+289.84%
CURRENT VS 20Y AVG
+363.12%
Cencora, Inc. EPS Basic Formula & Definition
EPS Basic is earnings per common share before the effect of potentially dilutive securities. It shows how much profit is attributable to each current common share.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cencora, Inc. EPS Basic FAQ
- What is the EPS basic for Cencora, Inc. (COR)?
- The EPS basic for COR stock is 13.04.
- Is Cencora, Inc.'s EPS basic high or low?
- Cencora, Inc.'s EPS basic of 13.04 is 236% above its 5-year average of 3.88, near the high end of its 5-year range (-16.60–13.04).
- What is the TTM average EPS basic for Cencora, Inc. (COR)?
- The TTM average EPS basic for COR stock is 7.81.
- What is the 3Y average EPS basic for Cencora, Inc. (COR)?
- The 3Y average EPS basic for COR stock is 8.10.
- What is the 5Y average EPS basic for Cencora, Inc. (COR)?
- The 5Y average EPS basic for COR stock is 3.88.
- What is the 10Y average EPS basic for Cencora, Inc. (COR)?
- The 10Y average EPS basic for COR stock is 3.88.
- What is the 15Y average EPS basic for Cencora, Inc. (COR)?
- The 15Y average EPS basic for COR stock is 3.34.
- What is the 20Y average EPS basic for Cencora, Inc. (COR)?
- The 20Y average EPS basic for COR stock is 2.82.
Cencora, Inc. EPS Basic History
| DATE | EPS BASIC |
|---|---|
| 2025-09-30 | 8.02 |
| 2024-09-30 | 7.60 |
| 2023-09-30 | 8.62 |
| 2022-09-30 | 8.15 |
| 2021-09-30 | 7.48 |
| 2020-09-30 | -16.60 |
| 2019-09-30 | 4.07 |
| 2018-09-30 | 7.61 |
| 2017-09-30 | 1.67 |
| 2016-09-30 | 6.73 |
| 2015-09-30 | -0.62 |
| 2014-09-30 | 1.22 |
| 2013-09-30 | 1.88 |
| 2012-09-30 | 2.84 |
| 2011-09-30 | 2.59 |
| 2010-09-30 | 2.26 |
| 2009-09-30 | 1.67 |
| 2008-09-30 | 0.78 |
| 2007-09-30 | 1.27 |
| 2006-09-30 | 1.14 |
| 2005-09-30 | 0.75 |
| 2004-09-30 | 1.05 |
| 2003-09-30 | 1.01 |
| 2002-09-30 | 0.82 |
| 2001-09-30 | 0.55 |
| 2000-09-30 | 0.48 |
| 1999-09-30 | 0.33 |
| 1998-09-30 | 0.26 |
| 1997-09-30 | 0.23 |
| 1996-09-30 | 0.20 |
Related Metrics
About Cencora, Inc.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Robert Mauch